
    
      Patients scheduled for primary laparoscopic sleeve gastrectomy for the treatment of morbid
      obesity will be assigned to receive tranexamic acid vs. placebo before surgery.
      Intraoperative bleeding will be scored, as well as postoperative bleeding and blood or
      blood-product requirements. POstoperative venous thromboembolic events will be recorded up to
      2 months following surgery.
    
  